Invention Grant
- Patent Title: Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
-
Application No.: US13917032Application Date: 2013-06-13
-
Publication No.: US09636314B2Publication Date: 2017-05-02
- Inventor: Kjeld Hermansen , Soren Gregersen , Per Bendix Jeppesen
- Applicant: Stevia Limited
- Applicant Address: GB London
- Assignee: Stevia Limited
- Current Assignee: Stevia Limited
- Current Assignee Address: GB London
- Agency: Browdy and Neimark, P.L.L.C.
- Main IPC: A61K31/19
- IPC: A61K31/19 ; A61K31/015 ; C07C13/68 ; A61K31/192 ; A61K31/352 ; A61K31/70 ; A61K31/704 ; A61K36/00 ; A61K36/48 ; A61K38/16 ; A61K45/06 ; C07C61/35 ; C07H15/256
Abstract:
A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.
Public/Granted literature
Information query
